Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00600028
What this trial is testing

Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide

Who this might be right for
Idiopathic Pulmonary FibrosisCough
Johns Hopkins University 25
Not applicableStudy completedNCT06200714
What this trial is testing

A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib

Who this might be right for
Idiopathic Pulmonary FibrosisDiarrhoea
Boehringer Ingelheim 18
Testing effectiveness (Phase 2)Study completedNCT00047658
What this trial is testing

The Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
InterMune 32
Not applicableStudy completedNCT06485635
What this trial is testing

Real-life-persistence to Antifibrotic Treatments

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 10,646
Early research (Phase 1)Study completedNCT00563212
What this trial is testing

A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
NYU Langone Health 12
Post-approval studies (Phase 4)Study completedNCT02606877
What this trial is testing

Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 37
Early research (Phase 1)UnknownNCT05387785
What this trial is testing

Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Angion Biomedica Corp 20
Not applicableStudy completedNCT03078426
What this trial is testing

Lung MRI in the Management of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University Hospital, Bordeaux 60
Not applicableUnknownNCT04268485
What this trial is testing

Longitudinal Changes in Serum KL-6 in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Manchester University NHS Foundation Trust 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06736990
What this trial is testing

CAL101 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Calluna Pharma AS 150
Testing effectiveness (Phase 2)Study completedNCT04968574
What this trial is testing

A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Endeavor Biomedicines, Inc. 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07728721
What this trial is testing

Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Haisco Pharmaceutical Group Co., Ltd. 175
Not applicableActive Not RecruitingNCT04572958
What this trial is testing

Changes in iOS in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 132
Not applicableStudy completedNCT02315586
What this trial is testing

Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
National Heart, Lung, and Blood Institute (NHLBI) 63
Testing effectiveness (Phase 2)Looking for participantsNCT06747923
What this trial is testing

SB17170 Phase 2 Trial in IPF Patients

Who this might be right for
IPFIdiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)
SPARK Biopharma 30
Early research (Phase 1)Not Yet RecruitingNCT07329959
What this trial is testing

CAR-DC for End-Stage IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis(IPF)
Second Affiliated Hospital, Zhejiang University, School of Medicine 8
Not applicableLooking for participantsNCT07743996
What this trial is testing

Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Boehringer Ingelheim 100
Not applicableStudy completedNCT02596841
What this trial is testing

Lung Diffusing Capacity for Nitric Oxide as a Marker of Fibrotic Changes in Idiopathic Interstitial Pneumonias

Who this might be right for
Usual Interstitial PneumoniaNonspecific Interstitial Pneumonia
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 60
Early research (Phase 1)Study completedNCT06265532
What this trial is testing

Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hal Chapman 12
Not applicableActive Not RecruitingNCT06636487
What this trial is testing

Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)SarcoidosisBronchiectasis+2 more
Copenhagen University Hospital, Hvidovre 50
Next Page